Literature DB >> 20732933

Trastuzumab beyond progression: a challenge to translational oncology?

A Santoro1, G Gullo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20732933     DOI： 10.1093/annonc/mdq410

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Proposal for a novel methodology to screen and score cost versus survival for anticancer drugs in metastatic disease: could cost weigh in evaluation?

Authors:  Helmy M Guirgis
Journal:  J Oncol Pract       Date:  2012-07       Impact factor: 3.840

2.  Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016).

Authors:  Benjamin Daniels; Federico Girosi; Hanna Tervonen; Belinda E Kiely; Sarah J Lord; Nehmat Houssami; Sallie-Anne Pearson
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.